Nektar Pockets $220M

San Francisco-based Nektar Therapeutics (NASDAQ: NKTR) said today it has raised $220 million in net proceeds through a public offering of stock. The company agreed to sell 19 million shares of new stock, and has granted its underwriter the option to buy another 2.85 million more shares to cover over-allotments. Jefferies & Co. acted as the sole book-running manager of the deal.

Trending on Xconomy